DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Inventory Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual inventory in 2023 was 196.2 Million TWD , down -38.55% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly inventory in 2024 Q2 was 178.98 Million TWD , up 0.35% from previous quarter.
  • DIVA Laboratories, Ltd. reported annual inventory of 319.3 Million TWD in 2022, down -9.37% from previous year.
  • DIVA Laboratories, Ltd. reported annual inventory of 352.31 Million TWD in 2021, up 40.82% from previous year.
  • DIVA Laboratories, Ltd. reported quarterly inventory of 175.47 Million TWD for 2024 Q3, down -1.96% from previous quarter.
  • DIVA Laboratories, Ltd. reported quarterly inventory of 178.35 Million TWD for 2024 Q1, down -9.1% from previous quarter.

Annual Inventory Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Inventory of DIVA Laboratories, Ltd. (2023 - 2019)

Year Inventory Inventory Growth
2023 196.2 Million TWD -38.55%
2022 319.3 Million TWD -9.37%
2021 352.31 Million TWD 40.82%
2020 250.18 Million TWD 41.88%
2019 176.34 Million TWD 0.0%

Peer Inventory Comparison of DIVA Laboratories, Ltd.

Name Inventory Inventory Difference
BIONET Corp. 55.53 Million TWD -253.281%
Genetics Generation Advancement Corp. 34.79 Million TWD -463.84%
Welgene Biotech Co.,Ltd. 53.77 Million TWD -264.897%
Puriblood Medical Co., Ltd. 24.24 Million TWD -709.193%
TFBS Bioscience Inc. 8.84 Million TWD -2118.761%